← SynDRA
OXAPROZIN
SynDRA canonical compound SYN0003504 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | PTGS2 |
|---|
| Mechanism of action | Cyclooxygenase inhibitor |
|---|
| Indication | osteoarthritis | rheumatoid arthritis |
|---|
| Disease area | rheumatology |
|---|
All known targets
- PTGS1
- PTGS2
- EPHX2
- C5
- Ephx2
- FPR1
- NR4A2
- PTGS1; PTGS2
- RXRA
- RXRB
- RXRG
- SHMT2
Mechanisms of action (all sources)
- Cyclooxygenase inhibitor
- PTGS2 INHIBITOR
- PTGS1 INHIBITOR
- EPHX2 INHIBITOR
- Inhibitor
Drug classes
- Cyclooxygenase Inhibitors
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Enzyme Inhibitors
- Peripheral Nervous System Agents
- Sensory System Agents
- Nonsteroidal Anti-inflammatory Drug
ATC classes
- M01A · ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
Cross-references
Synonyms
- alvo
- oxaprozin potassium
- WY 21743
- Oxaprozine
- Oxaprozina
- Coxanto
- NSC-310839
- WY-21,743
- WY-21743
- Daypro
- Actirin
- Alvo
- Danoprox
- Dayrun
- Deflam
- Oxaprozinum
- Voir
- Xopane
- Apotex brand of oxaprozin
- CSC brand of oxaprozin
- Pfizer brand of oxaprozin
- Rhoxalpharma brand of oxaprozin
- TRB brand of oxaprozin
- Lyl)propenoic acid
- NCI310839
- O 9637
- Apo-Oxaprozin
- Daypro (TN)
- Duraprox (TN)
- Oxaprozina [INN-Spanish]
- Oxaprozine [INN-French]
- Oxaprozinum [INN-Latin]
- Rhoxal-oxaprozin
- Oxaprozin (JP15/USAN/INN)
- Oxaprozin [USAN:BAN:INN:JAN]
- Beta-(4,5-Diphenyloxazol-2-yl)propionic acid
- 3-(4, 5-Diphenyl-2-oxazo
- 3-(4,5-Diphenyl-1,3-oxazol-2-yl)propanoic acid
Reported adverse events
- Bleeding
- GI bleed
- Perforation
- Ulceration
- Elderly
- Stevens-Johnson syndrome
- Hepatotoxicity
- Hypertension
- Abdominal pain
- Agranulocytosis
- Alopecia
- Anxiety
Look up OXAPROZIN in the interactive SynDRA portal →